Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL428880 (Acide cromoglicique, Acido cromoglicico, Cromo-comod, Cromoglicate, Cromoglicic acid, Cromoglycate, Cromolyn, R03BC01) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
GPR35/G-protein coupled receptor 35 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1293267] [GtoPdb: 102] [UniProtKB: Q9HC97] | ||||||||
ChEMBL | Competitive binding affinity to Nluc-fused human GPR35 expressed in CHO-K1 cells assessed as inhibition constant using furimazine as substrate incubated for 30 mins followed by substrate addition by in presence of 10-(4-(2-(4-(4-((2,8-dicarboxy-6-hydroxy-10-methylpyrido[3,2-g]quinolin-4-yl)oxy)butyl)-1H-1,2,3-triazol-1-yl)ethoxy)phenyl)-5,5-difluoro-2,7,9-trimethyl-5H-imidazo[1,2-c]pyrrolo[2,1-f][1,3,2]diazaborinin-6-ium-5-uide | B | 5.53 | pKi | 2970 | nM | Ki | ACS Med Chem Lett (2023) 14: 411-416 [PMID:37077394] |
ChEMBL | Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells by liquid scintillation counting analysis | B | 5.63 | pKi | 2340 | nM | Ki | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at human GPR35 by beta-arrestin recruitment assay | F | 5.1 | pEC50 | 8000 | nM | EC50 | Bioorg Med Chem (2023) 96: 117511-117511 [PMID:37976806] |
ChEMBL | Agonist activity at human GPR35 expressed in CHO-K1 cells after 90 mins by beta-arrestin 2 recruitment assay | B | 5.15 | pEC50 | 7000 | nM | EC50 | J Med Chem (2017) 60: 362-372 [PMID:27976894] |
ChEMBL | Agonist activity at GPR-35 (unknown origin) by beta-arrestin assay | B | 5.15 | pEC50 | 7000 | nM | EC50 | ACS Med Chem Lett (2023) 14: 411-416 [PMID:37077394] |
ChEMBL | Agonist activity at human GPR35 by DMR assay | B | 6.28 | pEC50 | 520 | nM | EC50 | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at GPR-35 (unknown origin) expressed in HT-29 cells by DMR assay | B | 6.28 | pEC50 | 520 | nM | EC50 | ACS Med Chem Lett (2023) 14: 411-416 [PMID:37077394] |
ChEMBL | Agonist activity at human GPR35 by Ca+2 release assay | B | 6.68 | pEC50 | 210 | nM | EC50 | J Med Chem (2013) 56: 7084-7099 [PMID:23888932] |
ChEMBL | Agonist activity at human GPR35 expressed in CHO-K1 cells by DMR assay | B | 7.28 | pEC50 | 52 | nM | EC50 | J Med Chem (2017) 60: 362-372 [PMID:27976894] |
GPR35/G-protein coupled receptor 35 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2390813] [GtoPdb: 102] [UniProtKB: Q9ES90] | ||||||||
ChEMBL | Agonist activity at mouse GPR35 by beta-arrestin recruitment assay | F | 4.24 | pEC50 | 58000 | nM | EC50 | Bioorg Med Chem (2023) 96: 117511-117511 [PMID:37976806] |
TAS2R7 in Human [GtoPdb: 663] [UniProtKB: Q9NYW3] | ||||||||
GtoPdb | - | - | 2.35 | pEC50 | 4500000 | nM | EC50 | Chem Senses (2010) 35: 157-70 [PMID:20022913] |
TAS2R20 in Human [GtoPdb: 671] [UniProtKB: P59543] | ||||||||
GtoPdb | - | - | 4.35 | pEC50 | 45000 | nM | EC50 | Chem Senses (2010) 35: 157-70 [PMID:20022913] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]